Cligosiban
Cligosiban is a pharmaceutical compound that has been investigated for its potential use in treating premature ejaculation (PE) in men. It is classified as a selective oxytocin receptor antagonist, which means it works by blocking the action of the hormone oxytocin in the body.
Mechanism of Action[edit | edit source]
Cligosiban functions by selectively inhibiting the oxytocin receptor. Oxytocin is a hormone that plays a significant role in social bonding, sexual reproduction, and during and after childbirth. In the context of premature ejaculation, oxytocin is believed to be involved in the ejaculatory reflex. By blocking oxytocin receptors, cligosiban may help delay ejaculation, thereby addressing the symptoms of PE.
Clinical Trials[edit | edit source]
Cligosiban has undergone several clinical trials to evaluate its efficacy and safety in treating premature ejaculation. These studies have aimed to determine the optimal dosage, assess the duration of its effects, and monitor any potential side effects. Results from these trials have shown promise, indicating that cligosiban may be effective in prolonging the time to ejaculation in men with PE.
Side Effects[edit | edit source]
As with any medication, cligosiban may cause side effects. Commonly reported side effects include headache, dizziness, and nausea. It is important for patients to discuss potential side effects with their healthcare provider before starting treatment.
Regulatory Status[edit | edit source]
As of the latest updates, cligosiban is still under investigation and has not yet received approval from major regulatory bodies such as the Food and Drug Administration (FDA) or the European Medicines Agency (EMA) for the treatment of premature ejaculation.
Research and Development[edit | edit source]
Research into cligosiban is ongoing, with scientists exploring its potential applications beyond premature ejaculation. The role of oxytocin in various physiological and psychological processes makes cligosiban a compound of interest for other conditions where oxytocin may play a role.
Also see[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
